Benchmarking Mutation Diagnostics in Lung Cancer
Author Information
Author(s): Querings Silvia, Altmüller Janine, Ansén Sascha, Zander Thomas, Seidel Danila, Gabler Franziska, Peifer Martin, Markert Eva, Stemshorn Kathryn, Timmermann Bernd, Saal Beate, Klose Stefan, Ernestus Karen, Scheffler Matthias, Engel-Riedel Walburga, Stoelben Erich, Brambilla Elisabeth, Wolf Jürgen, Nürnberg Peter, Thomas Roman K.
Primary Institution: Max Planck Institute for Neurological Research and University of Cologne
Hypothesis
How do different mutation detection methods compare in their ability to identify EGFR mutations in non-small cell lung cancer (NSCLC)?
Conclusion
Massively parallel sequencing is the most sensitive method for detecting EGFR mutations in lung cancer, outperforming traditional dideoxy sequencing and pyrosequencing.
Supporting Evidence
- Massively parallel sequencing detected all relevant mutations in patients responding to EGFR inhibition.
- Dideoxy sequencing missed four responders and pyrosequencing missed two responders.
- Histopathological estimates of tumor content showed low correlation with the frequency of mutant alleles.
- Massively parallel sequencing identified a total of 18 mutations in EGFR and KRAS.
Takeaway
This study shows that some tests for cancer mutations miss important information, but a new method can find almost all the mutations that matter.
Methodology
The study validated dideoxy sequencing and pyrosequencing against massively parallel sequencing in clinical lung cancer specimens.
Potential Biases
The patient cohort was not representative of the general population, potentially skewing results.
Limitations
The sample size was limited, and the study was enriched for cases likely to be EGFR mutation-positive.
Participant Demographics
The study analyzed 24 tumor samples from 22 patients with histologically confirmed NSCLC.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website